New filling line offers flexibility for processing liquid and lyophilized products and a wide range of container types. Read More >>
The announced transaction is scheduled to close later in the second quarter of 2026.
With design support, manufacturing, assembly, labeling, packaging, and analytical testing – we help bring drug delivery systems to market.
Adds three antiviral assets spanning marketed and clinical-stage development, complementing its existing treatment portfolio.
Roark will play a key management role in the continued growth and expansion of the CS Analytical service offering.
Integrated offerings are designed for smarter, more compliant clinical and commercial packaging.
